Glp 1 Ras - Renal Disorders

Relevant Publications

Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis.

Issue Release: 2025

Therapeutic Potential of GLP-1 Receptor Agonists in Diabetes and Cardiovascular Disease: Mechanisms and Clinical Implications.

Issue Release: 2025

Clinical development of oral semaglutide for the treatment of type 2 diabetes mellitus: focusing on early phase clinical trials.

Issue Release: 2025

Comparative efficacy and tolerability of currently approved incretin mimetics: A systematic analysis of placebo-controlled clinical trials.

Issue Release: 2025

Dulaglutide use to improve binge eating behaviors in a person with type 2 diabetes and obesity.

Issue Release: 2025

Glucagon-like Peptide-1 receptor agonists for obstructive sleep apnea in patients with obesity and type 2 diabetes mellitus: a systematic review and meta-analysis.

Issue Release: 2025

Adverse drug reaction patterns of GLP-1 receptor agonists approved for obesity treatment: Disproportionality analysis from global pharmacovigilance database.

Issue Release: 2025

Comparative Effects of Exercise and GLP-1 RAs on Type 2 Diabetic Rat Model: A Systematic Review.

Issue Release: 2025

Persistence with once-weekly glucagon-like peptide 1 receptor agonist therapy decreases the risk of major adverse cardiovascular events: A retrospective analysis of patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease.

Issue Release: 2025

The Efficacy and Safety of GLP-1 RAs in the Modification of Cardiovascular Morbidity in Patients with Obesity Without Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials Involving 32,884 Patients.

Issue Release: 2025

Is Weight Loss the Main Driver for A1C Improvement by Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists? A 2.5-Year Analysis in Real-World Clinical Practice.

Issue Release: 2025

Glucagon-Like Peptide-1 Receptor Agonists in the Peri-Operative Period.

Issue Release: 2025

Cardiovascular Outcomes with GLP-1 RAs in Patients with Type 2 Diabetes Mellitus and Atrial Fibrillation.

Issue Release: 2025

Considerations for Perioperative Management Guidance Regarding GLP-1 Receptor Agonists: Evaluation of Current Practices and Future Directions.

Issue Release: 2025

Effect of glucagon-like peptide-1 receptor agonists on vascular risk factors among adults with type 2 diabetes and established atherosclerotic cardiovascular disease.

Issue Release: 2025

Mechanisms of GLP-1 receptor agonist-induced weight loss: A review of central and peripheral pathways in appetite and energy regulation.

Issue Release: 2025

GLP-1 RAs and Nonarteritic Anterior Ischemic Optic Neuropathy-Making Sense of the Data.

Issue Release: 2025

Real-world Associations Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Accounting for Longitudinal Glycemic Control.

Issue Release: 2025

Higher Compliance with Treatment Administration Instructions for Injectable Dulaglutide versus Oral Semaglutide Reported by People with Type 2 Diabetes in Clinical Practice Settings in Spain: The TRU-Experience Study.

Issue Release: 2025

A Comprehensive Review on the Pharmacokinetics and Drug-Drug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist.

Issue Release: 2025

Why is Glomerular Filtration Important in Renal Disorders?

What are the Benefits of Living Donation?

What are Immunosuppressive Medications?

What is Nephrotic Syndrome?

Are There Specific Tests for Autoimmune-Related Renal Disorders?

What is End Stage Renal Disease (ESRD)?

What is Acute Kidney Injury (AKI)?

How Does Renal Blood Flow Change in Renal Disorders?

Can Alcohol Cause Kidney Disease?

What is Cardiorenal Syndrome?

Glp 1 Ras - Renal Disorders

Relevant Publications

Partnered Content Networks

Relevant Topics